amoxapine has been researched along with Koch's Disease in 1 studies
Amoxapine: The N-demethylated derivative of the antipsychotic agent LOXAPINE that works by blocking the reuptake of norepinephrine, serotonin, or both; it also blocks dopamine receptors. Amoxapine is used for the treatment of depression.
amoxapine : A dibenzooxazepine compound having a chloro substituent at the 2-position and a piperazin-1-yl group at the 11-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, J | 1 |
| Sha, J | 1 |
| Strong, E | 1 |
| Chopra, AK | 1 |
| Lee, S | 1 |
1 other study available for amoxapine and Koch's Disease
| Article | Year |
|---|---|
FDA-Approved Amoxapine Effectively Promotes Macrophage Control of Mycobacteria by Inducing Autophagy.
Topics: Amoxapine; Animals; Autophagy; BCG Vaccine; Humans; Macrophages; Mammals; Mice; Mycobacterium tuberc | 2022 |